Immunogenomic landscape analyses of immune molecule signature-based risk panel for patients with triple-negative breast cancer

• Main Authors: Cun Liu (Author), Ye Li (Author), Xiaoming Xing (Author), Jing Zhuang (Author), Jigang Wang (Author), Chunyan Wang (Author), Lujun Zhang (Author), Lijuan Liu (Author), Fubin Feng (Author), Huayao Li (Author), Chundi Gao (Author), Yang Yu (Author), Jingyang Liu (Author), Changgang Sun (Author)
• Format: Book
• Published: Elsevier, 2022-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Triple-negative breast cancer (TNBC) presented as high heterogeneous immunogenicity that lacks useful clinical signatures to risk-stratify immune-benefit subtypes. We hypothesized that molecular-based phenotypic characterization of TNBC tumors and their immunity may overcome these challenges. We enr...